SCHEMBL25580640

SCHEMBL25580640

c1ccc(-c2ccc(N(c3ccc(-c4cccc(-c5ccccc5)c4-c4ccccc4-c4ccccc4)cc3)c3ccc(-n4c5ccccc5c5ccccc54)cc3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ATM Q13315 1/20 0.45
HDAC4 P56524 1/20 0.38
KMT2A Q03164 2/20 0.36
MAPK14 Q16539 1/20 0.34
IL1R1 P14778 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
PTPN1 P18031 2/20 0.32
HTR7 P34969 1/20 0.31
TSPO P30536 1/20 0.31
MAPK8 P45983 1/20 0.31
RORC P51449 1/20 0.30
PDE6D O43924 1/20 0.30
APP P05067 1/20 0.30
DUSP3 P51452 1/20 0.30
HTR6 P50406 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25580519 1.00 L3MBTL1 (0.45) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL25580707 0.97 L3MBTL1 (0.45) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL25580826 0.94 KDM4E (0.40) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL25580920 0.94 KDM4E (0.40) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL15752385 0.93 L3MBTL1 (0.52) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL20812946 0.93 L3MBTL1 (0.52) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL25580738 0.92 KDM4E (0.41) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL25580685 0.92 L3MBTL1 (0.41) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL24948437 0.92 L3MBTL1 (0.50) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL15752306 0.92 L3MBTL1 (0.50) L3MBTL1KDM4EATMHDAC4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 L3MBTL1 148/4885KDM4E 2752/4885ATM 2320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.